2021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management

被引：25

作者：

Ali, Haris ^{[1
]}

Bacigalupo, Andrea ^{[2
,3
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol & Hemopoiet Cell Transplantat, Div Leukemia, Duarte, CA USA

[2] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Diagnost Immagini Radioterapia & Onc, Rome, Italy

[3] Univ Cattolica Sacro Cuore, Dipartimento Sci Radiol & Ematol, Sez Ematol, Rome, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 11期

关键词：

INTENSITY CONDITIONING REGIMEN; AGNOGENIC MYELOID METAPLASIA; SURVIVAL; BLOOD; OUTCOMES; SYSTEM;

D O I：

10.1002/ajh.26349

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The number of patients with myelofibrosis (MF) undergoing an allogeneic hemopoietic stem cell transplantation (HSCT) is increasing: in the analysis of the European Group for Blood and Marrow Transplantation (EBMT) the number of MF has increased from 515 in 2014 to 748 in 2018 . This reflects the fact that HSCT is currently the only curative treatment, capable of inducing prolonged disease-free survival. Nevertheless, several problems prevent more patients from undergoing an allogeneic HSCT: we will be discussing indications for HSCT, comorbidities, splenomegaly, older age and disease phase. Donor type and stem cell source are less of a problem. Several transplant platforms exist, including different strategies for graft versus host disease (GvHD) prophylaxis, Age tailored conditioning regimens need to be implemented, to allow older and fragile patients to undergo an allogeneic HSCT.

引用

页码：1532 / 1538

页数：7

共 45 条

[1] Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J].

Al Malki, Monzr M. ;

Nathwani, Nitya ;

Yang, Dongyun ;

Armenian, Saro ;

Dadwal, Sanjeet ;

Salman, Jaroslava ;

Mokhtari, Sally ;

Cao, Thai ;

Sandhu, Karamjeet ;

Rouse, Michelle ;

Mei, Matthew ;

Ali, Haris ;

Parker, Pablo ;

Alvarnas, Joseph ;

Smith, Eileen ;

Donnell, Margaret O. ;

Marcucci, Guido ;

Snyder, David ;

Nademanee, Auayporn ;

Forman, Stephen J. ;

Stein, Anthony ;

Nakamura, Ryotaro .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) :1828-1835

[2] MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen [J].

Ali, Haris ;

Aldoss, Ibrahim ;

Yang, Dongyun ;

Mokhtari, Sally ;

Khaled, Samer ;

Aribi, Ahmed ;

Afkhami, Michelle ;

Al Malki, Monzr M. ;

Cao, Thai ;

Mei, Matthew ;

O'Donnell, Margaret ;

Salhotra, Amandeep ;

Pullarkat, Vinod ;

Yang, Lixin ;

Stein, Anthony S. ;

Marcucci, Guido ;

Forman, Stephen J. ;

Nakamura, Ryotaro ;

Pillai, Raju ;

Snyder, David .

BLOOD ADVANCES, 2019, 3 (01) :83-95

[3] A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations [J].

Atilla, Erden ;

Atilla, Pinar Ataca ;

Demirer, Taner .

BALKAN MEDICAL JOURNAL, 2017, 34 (01) :1-9

[4] Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type [J].

Bacigalupo, A. ;

Soraru, M. ;

Dominietto, A. ;

Pozzi, S. ;

Geroldi, S. ;

Van Lint, M. T. ;

Ibatici, A. ;

Raiola, A. M. ;

Frassoni, F. ;

De Stefano, F. ;

Verdiani, S. ;

Casarino, L. ;

Barosi, G. .

BONE MARROW TRANSPLANTATION, 2010, 45 (03) :458-463

[5] Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes [J].

Bannow, Bethany T. Samuelson ;

Salit, Rachel B. ;

Storer, Barry E. ;

Stevens, Emily A. ;

Wu, David ;

Yeung, Cecilia ;

Fang, Min ;

Petersdorf, Effie W. ;

Linenberger, Michael L. ;

Woo, Janghee ;

Sorror, Mohamed L. ;

Doney, Kris ;

Sandmaier, Brenda M. ;

Deeg, H. Joachim ;

Scott, Bart L. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) :386-392

[6] Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet [J].

Barbuil, Tiziano ;

Tefferi, Ayalew ;

Vannucchi, Alessandro M. ;

Passamonti, Francesco ;

Silvers, Richard T. ;

Hoffman, Ronald ;

Verstovsek, Srdan ;

Mesa, Ruben ;

Kiladjian, Jean-Jacques ;

Hehlmann, Rudiger ;

Reiter, Andreas ;

Cervantes, Francisco ;

Harrison, Claire ;

Mc Mullin, Mary Frances ;

Hasselbalch, Hans Carl ;

Koschmieder, Steffen ;

Marchetti, Monia ;

Bacigalupo, Andrea ;

Finazzil, Guido ;

Kroeger, Nicolaus ;

Griesshammer, Martin ;

Birgegard, Gunnar ;

Barosi, Giovanni .

LEUKEMIA, 2018, 32 (05) :1057-1069

[7] Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen [J].

Chiusolo, Patrizia ;

Bregante, Stefania ;

Giammarco, Sabrina ;

Lamparelli, Teresa ;

Casarino, Lucia ;

Dominietto, Alida ;

Raiola, Anna Maria ;

Metafuni, Elisabetta ;

Di Grazia, Carmen ;

Gualandi, Francesca ;

Sora, Federica ;

Laurenti, Luca ;

Sica, Simona ;

Barosi, Gianni ;

Guolo, Fabio ;

Rossi, Monica ;

Rossi, Elena ;

Vannucchi, Alessandro ;

Signori, Alessio ;

De Stefano, Valerio ;

Bacigalupo, Andrea ;

Angelucci, Emanuele .

AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (02) :234-240

[8] Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation? [J].

Ciurea, Stefan O. ;

Kongtim, Piyanuch ;

Varma, Ankur ;

Rondon, Gabriela ;

Chen, Julianne ;

Srour, Samer ;

Bashir, Qaiser ;

Alousi, Amin ;

Mehta, Rohtesh ;

Oran, Betul ;

Popat, Uday ;

Hosing, Chitra ;

Olson, Amanda ;

Daver, Naval ;

Konopleva, Marina ;

Champlin, Richard E. .

BLOOD, 2020, 135 (06) :449-452

[9] Allogeneic stem cell transplantation for myelofibrosis patients aged ≥65 years [J].

Daghia, Giulia ;

Zabelina, Tatjana ;

Zeck, Gaby ;

von Pein, Ute-Marie ;

Christopeit, Maximilian ;

Wolschke, Christine ;

Ayuk, Francis ;

Kroeger, Nicolaus .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (04) :370-378

[10] Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation [J].

Ecsedi, Matyas ;

Schmohl, Joerg ;

Zeiser, Robert ;

Drexler, Beatrice ;

Halter, Jorg ;

Medinger, Michael ;

Duyster, Justus ;

Kanz, Lothar ;

Passweg, Jakob ;

Finke, Juergen ;

Bethge, Wolfgang ;

Lengerke, Claudia .

ANNALS OF HEMATOLOGY, 2016, 95 (10) :1627-1636

← 1 2 3 4 5 →